MRI GLOBAL - MILLER DMFP
$1,311,541N01FY2023DANIH
Midwest Research Institute, Kansas City MO
Investigators
Abstract
Developing nonmuscle II inhibitors for substance use relapse. NIH Blueprint Neurotherapeutics Network (BPN) for Small Molecules
View original record on NIH RePORTER →